To impulse the education and research of cannabis with an emphasis in the pharmaceutics and medical
to contribute to establishing the best regulatory model of the cannabis in favor of the public
well as providing knowledge based in evidence for the health professionals.
To bind the most relevant figures of cannabis investigation and medical and pharmacology teaching in
structuring a pedagogic program that creates an impact and coverage, nationally and internationally,
to make a
high-quality symposium, that will be a global referent on scientific encounters about the medical
uses of cannabis.
Participation of national media to reunite health professionals, journalists, and key investigators
in the wake of
future medical applications of cannabis.
Simposio Médico Farmacéutico sobre Cannabinoides
In June 2017 a decree was published on the Diario Oficial de la Federación to reform various laws in
the Health General
Law to permit medical uses of cannabis. Two years later, there is no corresponding regulation and
formal and regulated
access to safe medications based on cannabis.
That is why we firmly believe that education is a key factor to establish an effective regulatory
The capacitation actions that foment working under a scientific, updated, and internationally
upfront approach for
clinical and pharmacological research for specialists are scarce.
Since the discovery and characterization of the endocannabinoid system (ECS) at the early 90s, the
clinical and pharmacological
research in the world has been directed to find different uses and applications of cannabis and
cannabinoids in various pathologies.
Nowadays, there are thousands of protocols of basic research and more clinical trials, searching to
establish the foundations and
limits of the use of these drugs in the current clinical context. Even if there have been enormous
advances on the characterization
of the ECS’s physiology, there are still more answers regarding the cannabinoid medicine, in
particular if existent anecdotic evidence
is taken into account about the beneficial use of cannabis on diverse pathologies, and the lack of
controlled clinical trials that validate
with the necessary statistical and methodological force to guarantee its incorporation, as tools of
first-line in the therapeutic arsenal of
modern medics. For this reason, we, the organizers of the PHARMACANN MX 2019 symposium have the
mission of reuniting international experts in
physiology, pharmacology, clinic, and different aspects of cannabis sciences, in an effort to
approach the Mexican medics and health